CVS Health consensus builds among analysts, shares backed by Moderate Buy stance
28.06.2026 - 12:23:44 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-28, 12:23.
CVS Health Corp. (US1266501006) sits at the center of a clear analyst picture this weekend. On the NYSE, twenty-six research firms now collectively assign the shares a Moderate Buy rating, according to MarketBeat’s latest consensus update.
What the consensus shows
MarketBeat reports that the average recommendation on CVS Health is now classified as Moderate Buy, based on ratings from twenty-six covering firms that follow the healthcare group. Within that universe, several houses maintain Buy or Outperform stances that underpin a constructive view on the stock.
The same report cites a range of recent target price adjustments, including Wolfe Research, which earlier this year set an Outperform rating while trimming its target from 100 dollars to 97 dollars per share in a March 2 note. That move came after prior updates from other Wall Street firms who continue to track CVS Health alongside peers such as UnitedHealth Group and Walgreens Boots Alliance.
Ratings in the broader context
The Moderate Buy classification situates CVS Health between strong conviction Buy names and more cautious Hold-rated healthcare stocks in the S&P 500. For retail investors, the blend of Outperform and Buy ratings, combined with a narrower band of price targets around the high double-digit dollar zone, provides a clearer framework for how analysts value the company.
Consensus services such as MarketBeat aggregate these views from major houses including Goldman Sachs, JPMorgan and UBS, whose updates on U.S. healthcare names often reference reimbursement trends and the performance of insurance and pharmacy peers. In that environment, CVS Health appears as a diversified player across retail pharmacies, pharmacy benefits and health insurance, which typically draws sector comparisons to UnitedHealth Group and Cigna.
All news and analysis on the CVS Health shares
Further headlines, price data and analyst updates on CVS Health are bundled in the dedicated topic section and on the company’s Investor Relations page.
The business behind the stock
CVS Health generates revenue across three major segments: retail pharmacies, pharmacy benefit management through CVS Caremark, and health insurance via Aetna. In the retail division, iconic CVS Pharmacy stores in the U.S. dispense prescriptions, offer over-the-counter medicines and provide in-store health services.
Where the stock trades today
CVS Health Corp. (US1266501006) shares most recently closed on the NYSE at 104.38 dollars on 2026-06-26, 15:59 Eastern time.
Key data on the CVS Health shares
- Company: CVS Health Corp.
- ISIN: US1266501006
- WKN: 859034
- Ticker: CVS
- Trading venue: NYSE
- Price (as of 2026-06-26, 15:59): 104.38 USD
- Market cap: 133.0 billion USD (as of 2026-06-26)
- Sector / industry: Health Care / Managed Health Care and Retail Drugstores
- Index membership: S&P 500
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell securities. All data are based on sources cited and are subject to change.
